Cassio Murilo Trovo Hidalgo Filho

6PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursSub-acute carePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Overcoming Primary and Acquired Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies.

|Nov 05, 2024
Real-World Comparative Analysis of Liposomal Doxorubicin Versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma.

Mariana Carvalho Gouveia, Heloisa Guedes Andrade, Cassio Murilo Hidalgo Filho

|Jul 11, 2024
Unplanned Hospital Admissions in Patients With Solid Tumors in Brazil: Causes and Progressive Disease's Impact on Outcomes.

Cassio Murilo Hidalgo Filho, Felippe Lazar Neto, Vitor Pinheiro Sobottka

|Aug 31, 2022
Spiritual needs among hospitalized patients at a public hospital in Brazil: a cross-sectional study.

Cassio Murilo Trovo Hidalgo Filho, Ana Julia Aguiar de Freitas, Lucas Salviano de Abreu

|Nov 13, 2021
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review.

Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza

|Apr 03, 2021
A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.

Rhafaela Lima Causin, Ana Julia Aguiar de Freitas, Cassio Murilo Trovo Hidalgo Filho

Pageof 1